Not available
Quote | Community First Bancshares Inc. (NASDAQ:CFBI)
Last: | $10.08 |
---|---|
Change Percent: | -0.3% |
Open: | $10.0149 |
Close: | $10.08 |
High: | $10.18 |
Low: | $10.01 |
Volume: | 42,878 |
Last Trade Date Time: | 01/20/2021 04:55:45 pm |
News | Community First Bancshares Inc. (NASDAQ:CFBI)
(NewsDirect) Multiple countries are approving Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) ’s Namodenoson for compassionate use in patients with advanced liver cancer. These countries, including Romania and Israel, seem to have acknowledged Namodenoson...
(NewsDirect) The competition between pharmaceutical company trials to help the 2% to 3% of the population suffering from chronic psoriasis is heating up. Psoriasis is a chronic inflammatory skin disease caused by genetic disposition or environmental factors and is a burgeoning $16 b...
Message Board Posts | Community First Bancshares Inc. (NASDAQ:CFBI)
Subject | By | Source | When |
---|---|---|---|
welcome good luck to all | poor500 | investorshub | 08/31/2017 12:26:08 PM |
News, Short Squeeze, Breakout and More Instantly...
Community First Bancshares Inc. Company Name:
CFBI Stock Symbol:
NASDAQ Market:
(NewsDirect) Multiple countries are approving Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) ’s Namodenoson for compassionate use in patients with advanced liver cancer. These countries, including Romania and Israel, seem to have acknowledged Namodenoson...
(NewsDirect) The competition between pharmaceutical company trials to help the 2% to 3% of the population suffering from chronic psoriasis is heating up. Psoriasis is a chronic inflammatory skin disease caused by genetic disposition or environmental factors and is a burgeoning $16 b...
Community First Bancshares, Inc. (the “Company”), the stock holding company of Newton Federal Bank (the “Bank”), announced today that it has received all required regulatory approvals for the conversion of Community First Bancshares, MHC (the “MHC ...